Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
flow cytometry
technology11 mentionslast seen Nov 3, 2026
Method to characterize cell populations using fluorescent markers.
Relationships 6
- CyPath Lungdepends onflow cytometry99% confidence8 sources
- disease modeling platformdepends onflow cytometry90% confidence1 source
- Waters Corporationdevelopsflow cytometry90% confidence1 source
- CellCartadevelopsflow cytometry85% confidence1 source
- University of Hawaiʻi at Manoaimplementsflow cytometry85% confidence1 source
- flow cytometryapplies toprecision medicine80% confidence1 source
Relationship
CyPath Lungdepends onflow cytometry
99% confidence8 supporting mentions
Either name opens that entity’s relationships.
Sources 8
- filingSEC EDGAROct 29, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
CyPath Lung analyzes the lung microenvironment using advanced flow cytometry, AI-driven analysis, and a proprietary combination of the fluorescent porphyrin TCPP
- filingSEC EDGAROct 15, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
uses flow cytometry and proprietary artificial intelligence (AI) to identify cell populations
- filingSEC EDGAROct 13, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
CyPath Lung uses advanced flow cytometry and proprietary artificial intelligence (AI) to identify cell populations in patient sputum
- filingSEC EDGAROct 8, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
CyPath Lung uses flow cytometry and artificial intelligence
- filingSEC EDGAROct 6, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
CyPath Lung uses advanced flow cytometry and proprietary artificial intelligence (AI) to identify cell populations
- filingSEC EDGARSep 30, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
CyPath Lung uses advanced flow cytometry and proprietary artificial intelligence (AI)
- filingSEC EDGARSep 22, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
CyPath Lung uses advanced flow cytometry and proprietary artificial intelligence (AI)
- filingSEC EDGARSep 17, 2026bioAffinity Technologies, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
CyPath Lung uses advanced flow cytometry and proprietary artificial intelligence (AI) to identify cell populations in patient sputum